治疗前期望对电针与战地针灸治疗癌症幸存者疼痛结局的影响
本研究分析了一项随机临床试验数据,评估癌症幸存者接受电针或战地针灸前期望是否预测12周疼痛减轻。360名参与者中,治疗前期望在各组间无显著差异,校正协变量后,较高期望与疼痛减轻无显著关联。治疗前期望未预测电针或战地针灸的镇痛效果。
要点
- 癌症幸存者治疗前期望不预测电针或战地针灸的疼痛减轻。
- 电针组期望与疼痛变化无显著关联(Coef.=-0.05,95%CI -0.14~0.04)。
- 战地针灸组期望与疼痛变化无显著关联(Coef.=-0.07,95%CI -0.16~0.02)。
核心结论
- 治疗前期望未预测癌症幸存者接受电针或战地针灸后的疼痛减轻。
- 该研究有助于解释电针或战地针灸的镇痛效果并非仅是安慰剂效应。
研究设计与样本
- 分析了一项比较电针、战地针灸与等待对照组的随机临床试验数据。
- 共纳入360名癌症幸存者,平均年龄62.1岁(SD 12.7),女性251名(69.7%),非白人88名(24.4%)。
主要发现
- 基线时各组治疗前期望相似(电针13.9±3.6,战地针灸13.2±3.7,等待对照12.8±3.3,p=0.14)。
- 校正基线疼痛严重度、年龄、性别、种族和教育后,较高治疗前期望与更大疼痛减轻无显著关联(电针Coef.=-0.05,95%CI -0.14~0.04,p=0.28;战地针灸Coef.=-0.07,95%CI -0.16~0.02,p=0.15;等待对照Coef.=-0.09,95%CI -0.25~0.06,p=0.23)。
关键数值与推荐
- 治疗前期望采用针灸期望量表(AES)在基线测量。
- 疼痛严重度采用简明疼痛量表(BPI)在基线和第12周评估。
临床怎么用
- 临床中不应仅根据患者治疗前期望高低来预测电针或战地针灸的镇痛效果。
- 向癌症幸存者解释针灸镇痛效果时,可说明其并非单纯安慰剂效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Outcome expectancy is an important component of non-specific effect that may play an important role in pain research and clinical care. We sought to evaluate whether pretreatment expectancy predicts pain reduction in cancer survivors receiving electroacupuncture (EA) or battlefield acupuncture (BFA). METHODS: We analyzed data from a randomized clinical trial that compared EA and BFA versus wait list control (WLC) for chronic musculoskeletal pain in cancer survivors. Expectancy was measured by the Acupuncture Expectancy Scale (AES) at baseline. Pain severity was assessed using the Brief Pain Inventory (BPI) at baseline and week 12. For each treatment arm, multivariable regression models were used to evaluate the association between pretreatment expectancy and week 12 pain severity, controlling for baseline pain severity, age, sex, race, and education. RESULTS: Among 360 participants enrolled, the mean age was 62.1 years (SD 12.7), with 251 (69.7 %) women and 88 (24.4 %) non-white survivors. Pretreatment expectancy was similar for all groups at baseline (EA: 13.9 ± 3.6; BFA: 13.2 ± 3.7, WLC:12.8 ± 3.3, p = 0.14). Greater pretreatment expectancy was not significantly associated with greater pain reduction in any group, after adjusting for co-variates (EA: Coef. = -0.05, 95 % CI = -0.14 - 0.04, p = 0.28; BFA: Coef. = -0.07, 95 % CI = -0.16 - 0.02, p = 0.15; WLC: Coef. = -0.09, 95 % CI = -0.25 - 0.06, p = 0.23). CONCLUSIONS: Pretreatment expectancy did not predict pain reduction for either EA or BFA in cancer survivors. Our study contributes to the interpretation of analgesic effects of EA or BFA, beyond the notion of a mere 'placebo effect'.
引用
- Li X, Baser RE, Bryl K, et al. How does pretreatment expectancy influence pain outcomes with electroacupuncture and battlefield acupuncture in cancer survivors?: Pretreatment expectancy and pain reduction by acupuncture. Integr Med Res. 2024. PMID: 38721341. doi:10.1016/j.imr.2024.101040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。